LamdaGen Corporation is a private nano-based technology platform company who is the first to produce commercial LSPR (Localized Surface Plasmon Resonance) products. The products include highly sensitive biosensors for licensing to IVD and POC companies, LSPR-based analytical instruments for drug discovery/development, and a diverse range of optical biosensors for research.
LamdaGen’s Plasmonic ELISA™ platform is ideally suited for In-Vitro and POC diagnostic systems, facilitating detection limits into the femtomolar range. The Company licenses its Plasmonic ELISA technology to diagnostic companies for integration into their IVD and POC systems.
Founded in 2005 and headquartered in Menlo Park, CA, the company’s products are based upon its patented LSPR surface technologies which produce highly robust sensors and sensor chips in the form of metallic thin films – and are the heart of the Company’s plasmonic diagnostic biosensor platforms and LightPath™ analytical systems.